Adult stem cells derived from bone marrow, connective tissue, and solid organs can exhibit a range of differentiation potentials. Some controversy exists regarding the classification of mesenchymal stem cells as bona fide stem cells, which is in part derived from the limited ability to propagate true clonal populations of precursor cells. We isolated putative mesenchymal stem cells from the connective tissue of an adult rat (rMSC), and generated clonal populations via three rounds of dilutional cloning. The replicative potential of the clonal rMSC line far exceeded Hayflick's limit of 50–70 population doublings. The high capacity for self-renewal in vitro correlated with telomerase activity, as demonstrated by telomerase repeat amplification protocol (TRAP) assay. Exposure to nonspecific differentiation culture medium revealed multilineage differentiation potential of rMSC clones. Immunostaining confirmed the appearance of mesodermal phenotypes, including adipocytes possessing lipid-rich vacuoles, chondrocytes depositing pericellular type II collagen, and skeletal myoblasts expressing MyoD1. Importantly, the spectrum of differentiation capability was sustained through repeated passaging. Furthermore, serum-free conditions that led to high-efficiency smooth muscle differentiation were identified. rMSCs plated on collagen IV-coated surfaces and exposed to transforming growth factor-β1 (TGF-β1) differentiated into a homogeneous population expressing α-actin and calponin. Hence, clonogenic analysis confirmed the presence of a putative MSC population derived from the connective tissue of rat skeletal muscle. The ability to differentiate into a smooth muscle cell (SMC) phenotype, combined with a high proliferative capacity, make such a connective tissue-derived MSC population ideal for applications in vascular tissue construction.
ArciniegasE.; SuttonA. B.; AllenT. D.; SchorA. M.Transforming growth factor beta 1 promotes the differentiation of endothelial cells into smooth muscle-like cells in vitro. J.Cell Sci.103(Pt. 2): 521–529; 1992.
2.
ArmbrusterB. N.; BanikS. S.; GuoC.; SmithA. C.; CounterC. M.N-terminal domains of the human telomerase catalytic subunit required for enzyme activity in vivo.Mol. Cell. Biol.21: 7775–7786; 2001.
3.
BallasC. B.; ZielskeS. P.; GersonS. L.Adult bone marrow stem cells for cell and gene therapies: Implications for greater use.J. Cell. Biochem. Suppl.38: 20–28; 2002.
4.
BeresfordJ. N.; BennettJ. H.; DevlinC.; LeboyP. S.; OwenM. E.Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J.Cell Sci.102(Pt. 2): 341–351; 1992.
BruderS. P.; JaiswalN.; HaynesworthS. E.Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive sub-cultivation and following cryopreservation.J. Cell. Biochem.64: 278–294; 1997.
ChengS. L.; YangJ. W.; RifasL.; ZhangS. F.; AvioliL. V.Differentiation of human bone marrow osteogenic stromal cells in vitro: Induction of the osteoblast phenotype by dexamethasone.Endocrinology134: 277–286; 1994.
10.
DessauW.; VertelB. M.; von der MarkH.; von der MarkK.Extracellular matrix formation by chondrocytes in monolayer culture.J. Cell Biol.90: 78–83; 1981.
11.
DevineS. M.; HoffmanR.Role of mesenchymal stem cells in hematopoietic stem cell transplantation.Curr. Opin. Hematol.7: 358–363; 2000.
12.
DigirolamoC. M.; StokesD.; ColterD.; PhinneyD. G.; ClassR.; ProckopD. J.Propagation and senescence of human marrow stromal cells in culture: A simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate.Br. J. Haematol.107: 275–281; 1999.
GrigoriadisA. E.; HeerscheJ. N.; AubinJ. E.Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: Effect of dexamethasone.J. Cell Biol.106: 2139–2151; 1988.
15.
GuerrieroV.Jr.; FloriniJ. R.Dexamethasone effects on myoblast proliferation and differentiation.Endocrinology106: 1198–1202; 1980.
16.
HautmannM. B.; MadsenC. S.; OwensG. K.A transforming growth factor beta (TGFbeta) control element drives TGFbeta-induced stimulation of smooth muscle alpha-actin gene expression in concert with two CArG elements.J. Biol. Chem.272: 10948–10956; 1997.
17.
HayflickL.The limited in vitro lifetime of human diploid cell strains.Exp. Cell Res.37: 614–636; 1965.
18.
HirschiK. K.; RohovskyS. A.; D'AmoreP. A.PDGF, TGF-beta, and heterotypic cell–cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate.J. Cell Biol.141: 805–814; 1998.
KimN. W.; WuF.Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP).Nucleic Acids Res.25: 2595–2597; 1997.
21.
KocO. N.; LazarusH. M.Mesenchymal stem cells: Heading into the clinic.Bone Marrow Transplant.27: 235–239; 2001.
22.
MadsenC. S.; HersheyJ. C.; HautmannM. B.; WhiteS. L.; OwensG. K.Expression of the smooth muscle myosin heavy chain gene is regulated by a negative-acting GC-rich element located between two positive-acting serum response factor-binding elements.J. Biol. Chem.272: 6332–6340; 1997.
23.
MergnyJ. L.; MaillietP.; LavelleF.; RiouJ. F.; LaouiA.; HeleneC.The development of telomerase inhibitors: The G-quartet approach.Anticancer Drug Des.14: 327–339; 1999.
24.
MuragliaA.; CanceddaR.; QuartoR.Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J.Cell Sci.113(Pt. 7): 1161–1166; 2000.
25.
NiklasonL. E.; GaoJ.; AbbottW. M.; HirschiK. K.; HouserS.; MariniR.; LangerR.Functional arteries grown in vitro.Science284: 489–493; 1999.
26.
NovikoffA. B.; NovikoffP. M.; RosenO. M.; RubinC. S.Organelle relationships in cultured 3T3-L1 preadipocytes.J. Cell Biol.87: 180–196; 1980.
27.
PhinneyD. G.Building a consensus regarding the nature and origin of mesenchymal stem cells.J. Cell. Biochem. Suppl.38: 7–12; 2002.
28.
PhinneyD. G.; KopenG.; RighterW.; WebsterS.; TremainN.; ProckopD. J.Donor variation in the growth properties and osteogenic potential of human marrow stromal cells.J. Cell. Biochem.75: 424–436; 1999.
29.
PittengerM. F.; MackayA. M.; BeckS. C.; JaiswalR. K.; DouglasR.; MoscaJ. D.; MoormanM. A.; SimonettiD. W.; CraigS.; MarshakD. R.Multilineage potential of adult human mesenchymal stem cells.Science284: 143–147; 1999.
30.
ShahN. M.; GrovesA. K.; AndersonD. J.Alternative neural crest cell fates are instructively promoted by TGF-beta superfamily members.Cell85: 331–343; 1996.
31.
TalliniG.; ParhamD. M.; DiasP.; Cordon-CardoC.; HoughtonP. J.; RosaiJ.Myogenic regulatory protein expression in adult soft tissue sarcomas. A sensitive and specific marker of skeletal muscle differentiation.Am. J. Pathol.144: 693–701; 1994.
32.
WagersA. J.; SherwoodR. I.; ChristensenJ. L.; WeissmanI. L.Little evidence for developmental plasticity of adult hematopoietic stem cells.Science297: 2256–2259; 2002.
33.
WakitaniS.; SaitoT.; CaplanA. I.Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine.Muscle Nerve18: 1417–1426; 1995.
34.
WarejckaD. J.; HarveyR.; TaylorB. J.; YoungH. E.; LucasP. A.A population of cells isolated from rat heart capable of differentiating into several mesodermal phenotypes.J. Surg. Res.62: 233–242; 1996.
35.
WilliamsJ. T.; SoutherlandS. S.; SouzaJ.; CalcuttA. F.; CartledgeR. G.Cells isolated from adult human skeletal muscle capable of differentiating into multiple mesodermal phenotypes.Am. Surg.65: 22–26; 1999.
36.
YamashitaJ.; ItohH.; HirashimaM.; OgawaM.; NishikawaS.; YurugiT.; NaitoM.; NakaoK.Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors.Nature408: 92–96; 2000.
37.
YangY.; BeqajS.; KempP.; ArielI.; SchugerL.Stretch-induced alternative splicing of serum response factor promotes bronchial myogenesis and is defective in lung hypoplasia.J. Clin. Invest.106: 1321–1330; 2000.
